Media

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. 

Hologic is committed to establishing and maintaining strong relationships with the media. This site contains useful information about our Company, including news releases, video and image galleries, and upcoming events.  Please contact us for additional information or questions.  

Recent News
Jan 16, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that it has priced and allocated its previously announced private offering of $1 billion in aggregate principal amount of senior notes as follows: (i)...

Jan 16, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that it has launched, subject to market and other conditions, a private offering of $1 billion in aggregate principal amount of senior notes, to be...

Jan 16, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that its CE-marked Aptima® HIV-1 Quant Dx assay has been awarded World Health Organization (WHO) prequalification for in vitro diagnostics. The Aptima...

Jan 11, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that Namal Nawana has been elected to the Company's Board of Directors, effective immediately. Mr. Nawana, who has more than 20 years of global...

Jan 9, 2018

Marlborough, Mass., January 9, 2018 — Hologic, Inc. (Nasdaq: HOLX) today announced it has obtained a CE Mark in Europe for the Brevera® breast biopsy system with CorLumina® imaging technology,...

More ›

Featured Video